The nation of Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive information.
This rejection came to light after a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
An official spokesperson has since explained that the US was requesting genetic material for research and profit while refused to share the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for further talks to secure a deal suitable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Implications
This development follows a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US following concerns were filed about the security of Kenyans' medical information.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance openness and accountability.
Based on reports, 16 African countries have to date agreed to these new agreements, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided immense benefits for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to share its genetic material and health information indefinitely, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our nation would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our people should a future disease outbreak emerge."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were upending frameworks already set up via the global organization.
Mangwana cited its Pandemic Benefit-Sharing system designed to manage potential global health emergencies.
"This system is intended to guarantee that when a nation provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to develop them."
These objections over the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome continued discussions with our US partners on how subsequent collaboration might be arranged in a manner that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but urged that talks need to persist since much of the nation's Aids initiatives depended on international support.
"Where technical issues exist, including those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group said.
The situation underscores the continuing debate between receiving vital foreign assistance and protecting a country's data in an ever more interconnected world.